Medical Device
Manufacturing
THE TRADE PAPER OF THE FACTORY FLOOR
Z-2255-2023Class II

NeuMoDx Cartridge-used for extraction, purification, amplification and detection of nucleic acids on the...

Neumodx Molecular, Inc. / initiated 2023-05-24 / Open, Classified / root cause: manufacturing process

NeuMoDx Molecular Inc began a recall of NeuMoDx Cartridge-used for extraction, purification, amplification and detection of nucleic acids on the NeuMoDx 288 and NeuMoDx 96 Molecular Systems (NeuMoDx... on . FDA classified it as Class II and gives the reason as "Top label on some of the NeuMoDx cartridges within these lots may have been incorrectly applied during the manufacturing process, resulting in encroachment into the PCR region. The misplaced label may interfere with the...". As of , the recall status on record is Open, Classified, and MDM tags the root cause as manufacturing process.

Recall record

Recall number
Z-2255-2023
Classification
Class II
Status
Open, Classified
Initiated
Posted
Recalling firm
Neumodx Molecular, Inc.
Product
NeuMoDx Cartridge-used for extraction, purification, amplification and detection of nucleic acids on the NeuMoDx 288 and NeuMoDx 96 Molecular Systems (NeuMoDx System(s) Ref: 100100
Product code
PPM General Purpose Reagent
Reason for recall
Top label on some of the NeuMoDx cartridges within these lots may have been incorrectly applied during the manufacturing process, resulting in encroachment into the PCR region. The misplaced label may interfere with the module s optics performance, thereby increasing the risk for false positive results
Root cause tag
manufacturing process
FDA root cause
Employee error
Action
Qiagen issued customers "Urgent: Medical Device Correction" Letter via email on 5/24/23. Letter states reason for recall, health risk and action to take: If you have remaining stock of cartridges LOT 117514, 117524 or 117528, REF 100100, do not use it. Please contact QIAGEN Technical Service for a free-of-charge replacement. Dispose of the product LOT 117514, 117254, and 117528 in accordance with your national and local safety and environmental regulations. If you have already used NeuMoDx Cartridges from this LOT, please review all results obtained with the laboratory director and assess whether retesting is required. Review this notice with your laboratory/medical director. Important: Forward this information to all individuals and departments within your organization using the above listed cartridges. If you are not the end user, please forward this notice to the product end user. Complete Acknowledgement of Receipt attached to this letter by as soon as possible. If you have any questions or concerns, please contact your local QIAGEN Technical Service Department through any of the following: www.qiagen.com/QIAGEN-Subsidiaries.
Quantity in commerce
20,016 cartridges
Distribution
US Nationwide Distribution to states of: Kansas, Florida, Texas, Ohio, New York, Michigan, Pennsylvania; and OUS (Foreign) to countries of: AT, BE, CH, DE, ES, FI, FR, GB, IT, LV, PL, RO, SE
Product codes and lots
GTIN: 10814278020274 Lot Numbers: 117514, 117524, and 117528

Enforcement reports

One row per recalled product line
FDA enforcement reports joined to recall event Z-2255-2023
Recall numberClassStatusVoluntary or mandatedReport dateClassified
Z-2255-2023Class IIOngoingVoluntary: Firm initiated